Policy brief
IDF policy recommendations to improve diabetes care
On the occasion of the BRICS Leaders Summit in China, 3-5 September 2017, IDF worked with its Members and BCV members in Brazil, South Africa and Russia to develop policy recommendations to improve access to diabetes care in their countries.
attachments-13.pdf
pdf
174KB
Policy brief
Perspectives of people living with diabetes
In December 2016, IDF held a consultation with the Blue Circle Voices (BCV) network to establish the priorities of the network. The main issues identified by BCV members were access and affordability of medicines, devices and medical care; education; prevention and discrimination. This document presents the four priorities with an IDF call to action to governments to improve them.
attachments-12.pdf
pdf
914KB
Policy brief
Integrating Diabetes Evidence into Practice
This publication of the IDF Europe Region identifies the local and European-wide challenges of implementing diabetes evidence into practice and makes recommendations based on the findings.
attachments-11.pdf
pdf
3MB
Toolkit
IDF diabetes advocacy toolkit UN High Level Meeting on NCDs 2018
This toolkit for IDF members provides information and tools to successfully engage with national policymakers to demand stronger action on diabetes on the road to the UN High Level Meeting on NCDs 2018.
Advocacy toolkit to the UN HLM 2018
pdf
7MB
Report
Highlights of the second BCV consultation
In June 2017, IDF held a second consultation with members of the IDF Blue Circle Voices network, focusing on barriers to access to diabetes care, medicines and supplies. Some 70 participants from across the world responded to the survey, identifying affordability as the main barrier.
attachments-10.pdf
pdf
363KB
Report
Global survey on Access to Medicines and Supplies for People with Diabetes
In 2016, IDF conducted a global survey on the perspective of people with diabetes and health professionals on access to medicines and supplies for people with diabetes. The report of the findings introduces diabetes and related medicines; provides the perspectives of people with diabetes and health professionals around the world on the availability, access and prices of medicines and supplies; and outlines public health policy solutions.
attachments-43.pdf
pdf
6MB